Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 502 (ZNF502) is a predicted DNA-binding transcription factor belonging to the C2H2-type zinc finger protein family[3][5]. ZNF502 likely acts in the nucleus to regulate gene expression by binding specific DNA sequences, possibly modulating transcription via RNA polymerase II-dependent pathways[3][5]. While the broader zinc finger family is involved in a wide range of cellular functions including transcriptional regulation, apoptosis, differentiation, and cell cycle control[1][2][4][6], there is currently limited specific functional or disease-related information available for ZNF502 itself. No evidence supports its current use as a direct therapeutic target or biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 502 (ZNF502).